Peptide
Showing 1 - 25 of 8,428
Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)
Recruiting
- Neuroendocrine Tumors
- Peptide Receptor Radionuclide Therapy
-
Rotterdam, South Holland, NetherlandsErasmus MC
May 19, 2023
Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)
Enrolling by invitation
- Cancer
- Solid Tumor
- Personalized Synthetic Long Peptide Vaccine
-
San Francisco, CaliforniaQuest Clinical Research
Feb 20, 2023
Collateral Ligament Injury of Stifle Joint Trial in Domagnano (Arthrys (Collagen Peptide solution), Depo medrol)
Completed
- Collateral Ligament Injury of Stifle Joint
- Arthrys (Collagen Peptide solution)
- Depo medrol
-
Domagnano, RSM, San MarinoTiss'You
Jul 30, 2023
Dental Caries Trial in Cairo (Peptide)
Completed
- Dental Caries
- Peptide
-
Cairo, EgyptFaculty of Dentistary - Al-Azhar University
Jan 4, 2023
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Safety Issues Trial in Kunming (Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber
Recruiting
- Safety Issues
- Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels
-
Kunming, Yunnan, ChinaKunming Tongren Hospital
Jul 27, 2023
White Spot Lesion Trial in Alexandria (Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR, Fluoride
Completed
- White Spot Lesion
- Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR
- Fluoride varnish (DURAFLOR
-
Alexandria, EgyptAlexandria Faculty of Dentistry
Feb 1, 2023
Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Neoantigen peptide vaccine
- Neoantigen-based DC immune preparation
-
Nanchang, Jiangxi, ChinaFirst Affiliated Hospital of Nanchang University
Mar 1, 2023
Acute Kidney Injury, Cardiac Surgery Trial (LSALT Peptide, Placebo)
Not yet recruiting
- Acute Kidney Injury
- Cardiac Surgery
- LSALT Peptide
- Placebo
- (no location specified)
May 25, 2023
Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)
Not yet recruiting
- Glioma, Malignant
- Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
- Hiltonol
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023
Peptide (CGRP) as Biomarker of Migraine
Recruiting
- Migraine
- Nociceptive Blink Reflex
-
Greifswald, GermanyUniversity Medicine Greifswald
Mar 3, 2023
Mild to Moderate Acne, Stiffness of Joint, Nec, Involving Ankle and Foot in MDR24_1, Other Specified Diseases of Hair and Hair
Active, not recruiting
- Mild to Moderate Acne
- +5 more
- Veg Collagen Peptide
- +3 more
-
Gandhi Nagar, Gujarat, IndiaNovoBliss Research Pvt Ltd
Jan 12, 2023
Pancreatic Cancer Trial in Herlev (drug, radiation, biological)
Not yet recruiting
- Pancreatic Cancer
- Nivolumab
- +3 more
-
Herlev, DenmarkHerlev & Gentofte University Hospital, Denmark
Feb 8, 2023
Dietary Exposure Trial in Liverpool, Newcastle (Peptamen 1.3 PHGG)
Recruiting
- Dietary Exposure
- Peptamen 1.3 PHGG
-
Liverpool, United Kingdom
- +1 more
Oct 20, 2023
Age-related Wet Macular Degeneration Trial in United States (CG-P5 peptide, Placebo, Aflibercept Injection [Eylea])
Not yet recruiting
- Age-related Wet Macular Degeneration
- CG-P5 peptide
- +2 more
-
Augusta, Georgia
- +3 more
Nov 13, 2023
Glucagon-like Peptide-1 Receptor Agonists According to Type 2
Recruiting
- Diabetes Mellitus, Type 2
- GLP-1 receptor agonist
-
Bari, ItalyAzienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023
Healthy Trial in Petaling Jaya (Placebo, Product containing marine collagen peptide and Coenzyme Q10.)
Recruiting
- Healthy
- Placebo
- Product containing marine collagen peptide and Coenzyme Q10.
-
Petaling Jaya, Selangor, MalaysiaUngku Shahrin Medical Aesthetic Research & Innovation (USMARI) C
Dec 27, 2022
Colpomycosis, Bacterial Vaginosis, Mixede Vaginitis Trial (Dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal Suppositories,
Recruiting
- Colpomycosis
- +2 more
- Dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal Suppositories
- Placebo dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal Suppositories
-
Brisbane, Queensland, AustraliaQ-Pharm Pty. Ltd
Oct 13, 2022
Pain Trial in Tallahassee (Collagen Peptides vs. Placebo)
Completed
- Pain
- Collagen Peptides vs. Placebo
-
Tallahassee, FloridaInstitute of Sports Science and Medicine, Florida State Universi
Feb 22, 2023
Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP
Completed
- Prostate Specific Antigens
- Prostate Neoplasms
- T-cell receptor alternate reading frame protein (TARP) peptide vaccine
- T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022
Fibrolamellar Hepatocellular Carcinoma Trial in Tuebingen (Fusion-VAC-XS15)
Not yet recruiting
- Fibrolamellar Hepatocellular Carcinoma
-
Tuebingen, Baden-Würtemberg, GermanyUniversity Hospital Tuebingen
Jun 29, 2023
Pleural Effusion, Heart Failure, Malignant Tumor Trial
Not yet recruiting
- Pleural Effusion
- +7 more
- (no location specified)
Mar 31, 2023
Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1
Not yet recruiting
- Overweight and Obesity
- 24-hour ambulatory blood pressure
- Liberal salt diet
- (no location specified)
Oct 4, 2023
Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)
Completed
- Leukemia, Chronic Lymphatic
- Peptide Vaccine
- Imiquimod
-
Stuttgart, Baden-Wuerttemberg, Germany
- +4 more
Nov 24, 2022
Postsphincterotomy Bleeding WithNovel Self-assembling Peptide
Recruiting
- Biliary Obstruction
- Complication of Treatment
- A novel hemostatic agent (Purastat®)
-
Prague, CzechiaPetr Hrabak
May 23, 2023